Business Description
Biolase Inc
NAICS : 339114
SIC : 5047
ISIN : US0909112072
Description
Biolase Inc is a United States-based provider of laser systems for the dental industry. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.36 | |||||
| Equity-to-Asset | -0.14 | |||||
| Debt-to-Equity | -3.38 | |||||
| Debt-to-EBITDA | -1.03 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -15.52 | |||||
| Beneish M-Score | -3.81 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -65.7 | |||||
| 3-Year EBITDA Growth Rate | 72.4 | |||||
| 3-Year EPS without NRI Growth Rate | 72.5 | |||||
| 3-Year FCF Growth Rate | 71.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.87 | |||||
| 9-Day RSI | 45.88 | |||||
| 14-Day RSI | 42.58 | |||||
| 6-1 Month Momentum % | -49.77 | |||||
| 12-1 Month Momentum % | -98.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.71 | |||||
| Quick Ratio | 0.36 | |||||
| Cash Ratio | 0.17 | |||||
| Days Inventory | 143.64 | |||||
| Days Sales Outstanding | 41.36 | |||||
| Days Payable | 70.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -343.8 | |||||
| Shareholder Yield % | -181.14 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.01 | |||||
| Operating Margin % | -35.84 | |||||
| Net Margin % | -41.65 | |||||
| FCF Margin % | -25.84 | |||||
| ROE % | -21668.17 | |||||
| ROA % | -53.78 | |||||
| ROIC % | -80.56 | |||||
| ROC (Joel Greenblatt) % | -178.37 | |||||
| ROCE % | -123.09 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.68 | |||||
| EV-to-EBITDA | -0.8 | |||||
| EV-to-Forward-EBITDA | -1.96 | |||||
| EV-to-Revenue | 0.25 | |||||
| EV-to-Forward-Revenue | 0.22 | |||||
| EV-to-FCF | -0.95 | |||||
| Price-to-Median-PS-Value | 0.01 | |||||
| Earnings Yield (Greenblatt) % | -147.06 | |||||
| FCF Yield % | -598.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BIOL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biolase Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 46.097 | ||
| EPS (TTM) ($) | -10.862 | ||
| Beta | 0.58 | ||
| Volatility % | 110.85 | ||
| 14-Day RSI | 42.58 | ||
| 14-Day ATR ($) | 0.01027 | ||
| 20-Day SMA ($) | 0.058857 | ||
| 12-1 Month Momentum % | -98.61 | ||
| 52-Week Range ($) | 0.036 - 5.32 | ||
| Shares Outstanding (Mil) | 36.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biolase Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biolase Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biolase Inc Frequently Asked Questions
What is Biolase Inc(BIOL)'s stock price today?
The current price of BIOL is $0.05. The 52 week high of BIOL is $5.32 and 52 week low is $0.04.
When is next earnings date of Biolase Inc(BIOL)?
The next earnings date of Biolase Inc(BIOL) is 2024-11-08 Est..
Does Biolase Inc(BIOL) pay dividends? If so, how much?
Biolase Inc(BIOL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers